People
According to reports, Novartis veteran Jonathan Symonds is likely to be named the next chairman of the board.
At Kite, Shaw will focus on turning around the company’s flagship CAR-T treatment Yescarta, as well as focus on the development of other cancer-targeting cell therapies.
With a clear vision in mind Iperion Life Sciences Consultancy has taken the next step in realizing her mission.
Biotech and pharma companies strengthen their leadership teams with new appointments.
AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, announced the hiring of Jay Mohr as Chief Operating Officer, Chief Business Officer, and Head of Commercial Development.
Start Codon, a new model of life science and healthcare business accelerator, announced two appointments to its senior team.
Ergomed plc, a company focused on providing specialised services to the pharmaceutical industry, is pleased to announce its intention to appoint Dr Jim Esinhart as a Non-Executive Director of the Company.
Recce Pharmaceuticals Ltd, the company developing a new class of synthetic antibiotics, announced that Dr John Prendergast has been appointed to Independent Chair with founder Dr Graham Melrose stepping back from the role of Executive Chair to Executive Director and Chief Research Officer.
A recent report from Business Insider ranked the 50 worst places in the United States for traffic commutes and the main biotech hubs were all included.
There is, thankfully, no age limit on innovation—you can do it at any age. But for many, “young,” counts as under 30, sometimes under 35, or even under 40, at least in terms of putting together lists of scientific innovators.
PRESS RELEASES